Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/INNATE-PHARMA-35620/attualita/Innate-Pharma-annuncia-la-presentazione-bis-dei-risultati-intermedi-dello-studio-di-Fase-2-TELLOMAK-44902351/?utm_source=whatsapp&utm_medium=social&utm_campaign=share